Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
about
Ovarian cancer screening--current status, future directionsDevelopment of nanoscale approaches for ovarian cancer therapeutics and diagnosticsA critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass.Preclinical evaluation of the novel monoclonal antibody H6-11 for prostate cancer imaging.Label-free LC-MSe in tissue and serum reveals protein networks underlying differences between benign and malignant serous ovarian tumors.Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkersApplication of proteomics to cancer early detectionProteomics in cancer biomarkers discovery: challenges and applications.Transcriptomic landscape of breast cancers through mRNA sequencing.Multianalyte assay systems in the differential diagnosis of ovarian cancer.Up-Regulation of Antioxidant Proteins in the Plasma Proteome during Saturation Diving: Unique Coincidence under Hypobaric Hypoxia.Ovarian cancer: can proteomics give new insights for therapy and diagnosis?Identification of PTHrP(12-48) as a plasma biomarker associated with breast cancer bone metastasis.Biomarker testing for ovarian cancer: clinical utility of multiplex assaysOvarian cancer molecular pathology.From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade.The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression.Epidemiologic design and analysis for proteomic studies: a primer on -omic technologies.Cancer proteomics: developments in technology, clinical use and commercialization.Current state of biomarkers in ovarian cancer prognosis.Proteomic Profiling of Serial Prediagnostic Serum Samples for Early Detection of Colon Cancer in the U.S. Military.Iron overload and altered iron metabolism in ovarian cancer.Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen.Biases introduced by choosing controls to match risk factors of cases in biomarker researchProtein and glycomic plasma markers for early detection of adenoma and colon cancer.Detection of the ovarian cancer biomarker CA-125 using chemiluminescence resonance energy transfer to graphene quantum dots.
P2860
Q27004471-EACD7041-12BE-446B-B8A0-EB05BAB4D664Q30421664-B6CCF3E5-0DFB-4902-A316-16489C0D58D3Q30528206-0E46340F-A3E0-487C-A79E-32B7AB0349AEQ33652622-62EF960C-97F4-47BD-A30F-CC30288F555FQ34267969-C6954153-BF6E-4FAF-8CBF-D5E9E28EFA71Q34412873-326F28A3-ED7B-47C4-A204-7FD428CEAA8DQ35053031-7B9FFAFB-7B2F-4F35-9EEA-A25C8BE98146Q35592114-2E019E79-319E-4FF7-99EC-DE34725B87EFQ35755270-DFCE69AA-EFBA-44FA-9C9D-4B13CF75A821Q35854476-B7D47DFA-C1DC-4466-B5C1-29FB3037D2BCQ36163719-0AB8A446-3427-4592-BEBA-C3443C9E814DQ36820579-00F898EA-E94D-4157-A009-708AFC6F5612Q36837041-55193F6A-8DB6-494D-BB93-944A8510C1DCQ36897149-12C4F7CD-54DD-4336-8605-AABA90703CA9Q38021356-1481695E-A5DB-4830-BEE6-266BC341ECBBQ38052927-C6C6D6FA-C28C-4B10-9CB1-64C8F4E6CEB4Q38100999-899443AB-FADF-4D9F-91D1-E91DCE004BFBQ38384848-317EFE42-AA32-45E4-A68E-5B609EBF2C0FQ38543009-6E44A922-F33E-4E62-BEC1-070DB813CE3CQ38628964-58CAFA47-DFD2-4ECE-96F4-20D75C21DB97Q39076980-51814CA8-14E5-4418-9CF5-ECA0BFECB33DQ39092091-63D890DC-8FF6-4799-AD15-F4CD244D4191Q41512697-8A859A3B-86CA-4313-B61B-1D19DBE6D945Q41980560-45B73146-6D34-4F94-B40C-0D3307BB4148Q46447113-B1E863A2-668B-4993-958F-1239312ED6EDQ53654158-4414F965-07ED-4461-AA75-FF78E6F830DD
P2860
Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Proteomic biomarkers in combin ...... (PLCO) Cancer Screening Trial.
@ast
Proteomic biomarkers in combin ...... (PLCO) Cancer Screening Trial.
@en
type
label
Proteomic biomarkers in combin ...... (PLCO) Cancer Screening Trial.
@ast
Proteomic biomarkers in combin ...... (PLCO) Cancer Screening Trial.
@en
prefLabel
Proteomic biomarkers in combin ...... (PLCO) Cancer Screening Trial.
@ast
Proteomic biomarkers in combin ...... (PLCO) Cancer Screening Trial.
@en
P2093
P2860
P356
P1433
P1476
Proteomic biomarkers in combin ...... (PLCO) Cancer Screening Trial.
@en
P2093
Eric T Fung
Karen H Lu
Lee E Moore
Ruth M Pfeiffer
Zhen Zhang
P2860
P304
P356
10.1002/CNCR.26241
P407
P577
2011-06-29T00:00:00Z